- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05823935
Laparoscopic Versus Vaginal Cuff Closure During LH in Benign Gynecological Lesions
April 9, 2023 updated by: Mansoura University
Laparoscopic Versus Vaginal Cuff Closure During Laparoscopic Hysterectomy in Benign Gynecological Lesions
To compare vaginal cuff closure via Bakay purse string with vaginal cuff closure via vaginal route with continuous locked suturing after total laparoscopic hysterectomy for benign lesions.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The objective of the present study is to compare 2 different methods for vaginal cuff closure after total laparoscopic hysterectomy for benign lesions regarding operative time, vaginal length, vaginal cuff dehiscene, hematoma formation.
The first method is the Bakay purse string and the second is the closure of the vault via vaginal route with continuous locked suturing.
Study Type
Interventional
Enrollment (Anticipated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ahmed M Elashry, MSc
- Phone Number: +201066556370
- Email: elashry11090@gmail.com
Study Contact Backup
- Name: Mohamed S Abdelhafez, MD
- Email: msabdelhafez@gmail.com
Study Locations
-
-
Dakahlia
-
Mansourah, Dakahlia, Egypt, 35111
- Recruiting
- Obstetrics and Gynecology Department in Mansoura University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Benign uterine lesions e.g fibroid, adenomyosis,…etc.
- Patient acceptance to undergo laparoscopic hysterectomy.
Exclusion Criteria:
- Gynecological malignancy.
- Low corporeal myoma obsecuring cervicovaginal junction.
- History of extensive abdominal surgery other than cesarean section.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Bakay purse string group
Bakay purse string will be used to close the vaginal cuff after total laparoscopic hysterectomy for benign lesions.
|
After developing the bladder flap, Vicryl polyglactin 910 sutures (Ethicon, Inc, Somerville, NJ) will be placed on the line between the cervicovaginal junction and the bladder starting at either 4 to 3 o'clock or 8 to 9 o'clock, as anchor sutures.
Paying attention not to get closer than 1 cm to the bladder, the first suture will be passed from 4 o'clock to 3 o'clock and continued circumferentially in a full-thickness purse string fashion through 3, 1, 10, 8, 7, 5 o'clock completing a circle while including both uterosacral ligaments.
|
Active Comparator: Cuff closure via vaginal route group
Vaginal cuff closure via vaginal route with continuous locked suturing will be used to close the vaginal cuff after total laparoscopic hysterectomy for benign lesions.
|
After the uterus will be removed via vaginal route, vaginal cuff ends will be grasped via vaginal approach and sutured continuous locked sutures using Vicryl polyglactin 910 sutures in one layer.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total operative time
Time Frame: From start to end of operation
|
The time between placement of the operative ports and successful closure of the vaginal cuff
|
From start to end of operation
|
Operative time for colpotomy and vaginal cuff closure
Time Frame: From start colpotomy to end of vaginal cuff closure
|
The time between first anchor suture placement and successful closure of the vaginal cuff
|
From start colpotomy to end of vaginal cuff closure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ahmed M Elashry, MSc, Mansoura University
- Study Chair: Hamed M Youssef, MD, Mansoura University
- Study Director: Maged R Elshamy, MD, Mansoura University
- Study Director: Mahmoud M Awad, MD, Mansoura University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 5, 2022
Primary Completion (Anticipated)
November 1, 2023
Study Completion (Anticipated)
November 1, 2023
Study Registration Dates
First Submitted
April 9, 2023
First Submitted That Met QC Criteria
April 9, 2023
First Posted (Actual)
April 21, 2023
Study Record Updates
Last Update Posted (Actual)
April 21, 2023
Last Update Submitted That Met QC Criteria
April 9, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MD.22.10.703
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Uterine Diseases
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedUterine Corpus Leiomyosarcoma | Stage IIA Uterine Sarcoma | Stage IIB Uterine Sarcoma | Stage IIIA Uterine Sarcoma | Stage IIIB Uterine Sarcoma | Stage IIIC Uterine Sarcoma | Stage IVA Uterine Sarcoma | Stage IVB Uterine Sarcoma | Stage IA Uterine Sarcoma | Stage IB Uterine Sarcoma | Stage IC Uterine SarcomaUnited States
-
University of AarhusRecruitingUterine Cervical Neoplasm | Mass Screening | Uterine Cervical Disease | Uterine NeoplasmDenmark
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedUterine Carcinosarcoma | Stage IIA Uterine Sarcoma | Stage IIB Uterine Sarcoma | Stage IIIA Uterine Sarcoma | Stage IIIB Uterine Sarcoma | Stage IIIC Uterine Sarcoma | Stage IVA Uterine Sarcoma | Stage IVB Uterine Sarcoma | Stage IA Uterine Sarcoma | Stage IB Uterine Sarcoma | Stage IC Uterine SarcomaUnited States
-
GlaxoSmithKlineCompletedCervical Cancer | Neoplasms, Uterine Cervix
-
Huazhong University of Science and TechnologyChongqing University Cancer Hospital; Peking University People's Hospital; Qilu... and other collaboratorsRecruitingCervical Cancer | Uterine Cervical Cancer | Uterine Cervical NeoplasmChina
-
Huazhong University of Science and TechnologyUnknownCervical Cancer | Uterine Cervical Cancer | Uterine Cervical NeoplasmChina
-
Hillel Yaffe Medical CenterUnknownUterine Neoplasms | Uterine Cervical NeoplasmIsrael
-
Centre Oscar LambretTerminatedUterine Cervical CancerFrance
-
Ding MaRecruitingUterine Cervical NeoplasmChina
-
Karolinska InstitutetKarolinska University Hospital; Regional Cancer Centre Stockholm GotlandEnrolling by invitationUterine Cervical CancerSweden
Clinical Trials on Bakay purse string
-
University of MinnesotaCentre Hospitalier Universitaire VaudoisCompleted
-
Affiliated Hospital to Academy of Military Medical...UnknownIntervention | Gastrointestinal PerforationChina
-
Dr Cipto Mangunkusumo General HospitalCompleted
-
Combined Military Hospital, PakistanUnknownSurgical Site Infection | Difference in Surgical Site Infection According to Gender and Age GroupsPakistan
-
University of California, DavisCompleted
-
Dr. Lutfi Kirdar Kartal Training and Research HospitalCompletedPlacenta Accreta | Placenta Previa | Cesarean Section; ComplicationsTurkey
-
Dr. Lutfi Kirdar Kartal Training and Research HospitalCompletedCesarean Section ComplicationsTurkey
-
Seoul National University Bundang HospitalRecruitingSurgical Site Infection | Wound HealKorea, Republic of
-
Assiut UniversityNot yet recruitingCongenital Inguinal Hernia
-
Al-Azhar UniversityCompletedCongenital Inguinal HerniaEgypt